- Home
- TAL vs GKOS Comparison
TAL vs GKOS Comparison
Compare TAL & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAL
- GKOS
- Stock Information
- Founded
- TAL 2003
- GKOS 1998
- Country
- TAL China
- GKOS United States
- Employees
- TAL N/A
- GKOS N/A
- Industry
- TAL Other Consumer Services
- GKOS Medical/Dental Instruments
- Sector
- TAL Real Estate
- GKOS Health Care
- Exchange
- TAL Nasdaq
- GKOS Nasdaq
- Market Cap
- TAL 6.4B
- GKOS 5.4B
- IPO Year
- TAL 2010
- GKOS 2015
- Fundamental
- Price
- TAL $10.97
- GKOS $82.73
- Analyst Decision
- TAL Buy
- GKOS Strong Buy
- Analyst Count
- TAL 4
- GKOS 12
- Target Price
- TAL $12.66
- GKOS $128.58
- AVG Volume (30 Days)
- TAL 4.1M
- GKOS 655.8K
- Earning Date
- TAL 10-23-2025
- GKOS 11-03-2025
- Dividend Yield
- TAL N/A
- GKOS N/A
- EPS Growth
- TAL 91.79
- GKOS N/A
- EPS
- TAL 0.17
- GKOS N/A
- Revenue
- TAL $2,411,045,000.00
- GKOS $432,953,000.00
- Revenue This Year
- TAL $32.96
- GKOS $28.79
- Revenue Next Year
- TAL $23.43
- GKOS $25.65
- P/E Ratio
- TAL $64.50
- GKOS N/A
- Revenue Growth
- TAL 47.99
- GKOS 26.70
- 52 Week Low
- TAL $7.35
- GKOS $77.10
- 52 Week High
- TAL $15.30
- GKOS $163.71
- Technical
- Relative Strength Index (RSI)
- TAL 55.71
- GKOS 33.60
- Support Level
- TAL $10.35
- GKOS $86.81
- Resistance Level
- TAL $10.62
- GKOS $95.32
- Average True Range (ATR)
- TAL 0.29
- GKOS 2.79
- MACD
- TAL 0.01
- GKOS -0.88
- Stochastic Oscillator
- TAL 86.54
- GKOS 1.35
About TAL TAL Education Group
TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions. Among those business lines, TAL focuses on enrichment learning and content solutions.
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.